It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Interactions between the prokaryotic microbiome and eukaryotic parasites in the vertebrate gut may affect overall host health and disease. While intertropical areas exhibit a high rate of parasites carriers, such interactions are understudied in these populations. Our objectives were to (1) describe the gut microbiome of individuals living in Madagascar, (2) identify potential associations between bacterial taxa and parasites colonizing the digestive tract and (3) highlight main determinants of the gut microbiota composition in this developing country. Metadata (socioeconomic, diet, clinical) and fecal samples were collected from 219 volunteers from North-West Madagascar (Mahajanga). Fecal microbiome was assessed through 16S rRNA gene sequencing and metabolomics, and related to dietary habits and parasites carriage. We highlight important Malagasy gut microbiome peculiarities. Out of three detected enterotypes, only one is similar to that observed in Westernized countries (Ruminococcus-driven). Functions associated with the two others (Clostridium sensu stricto-driven and Escherichia/Shigella-driven) are mostly directed toward amino acids biosynthesis and degradation, respectively. Diet and protozoan carriage were the main drivers of microbiota composition. High protozoan carriage was associated with higher diversity, richness and microbial functionalities. The gut microbiome of Malagasy strongly differs from that of Westernized countries. Asymptomatic protozoan carriage and dietary habits are the external factors with the deepest impact on gut microbiome. Further studies are needed to understand whether gut microbial richness constitute a predilection niche for protozoans colonization, due to their gazing features, or whether the parasites themselves induce a higher bacterial richness.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Université Paris-Saclay, INRAE, AgroParisTech, Micalis Institute, Domaine de Vilvert, Jouy-en-Josas, France (GRID:grid.462293.8) (ISNI:0000 0004 0522 0627)
2 CHU Clermont-Ferrand, Laboratoire de Parasitologie-Mycologie, Clermont-Ferrand, France (GRID:grid.411163.0) (ISNI:0000 0004 0639 4151); Université Clermont Auvergne/Inserm U1071; USC-INRAE 2018, Microbes, Intestin, Inflammation et Susceptibilité de l’Hôte (M2iSH), 3iHP, Clermont-Ferrand, France (GRID:grid.411717.5) (ISNI:0000 0004 1760 5559)
3 Université de Strasbourg, Institut de Parasitologie et Pathologie Tropicale, Strasbourg, France (GRID:grid.11843.3f) (ISNI:0000 0001 2157 9291)
4 Facultés des Sciences, Toliara, Madagascar (GRID:grid.411717.5); Institut Pasteur de Madagascar, Antananarivo, Madagascar (GRID:grid.418511.8) (ISNI:0000 0004 0552 7303)
5 Université de Mahajanga, Laboratoire d’Analyse Médicale, CHU PZaGa, Mahajanga, Madagascar (GRID:grid.442587.8) (ISNI:0000 0004 0366 7353)
6 Service d’Hépato-Gastro-Entérologie, CHU Mahavoky Atsimo, Mahajanga, Madagascar (GRID:grid.442587.8)